Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Olaparib-Parp'
Olaparib-Parp published presentations and documents on DocSlides.
by littleccas
actual. . video-recorded proceedings from the . l...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
by alexa-scheidler
Phase I Study of Olaparib and Temozolomide, in pa...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Please note, these are the actual video-recorded
by blindnessinfluenced
proceedings from the live CME event and may includ...
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
PARPA II: INDICADORES DE MONITORIA E AVALIAÇÃO
by calandra-battersby
PARPA II: INDICADORES DE MONITORIA E AVALIAÇÃO ...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
by marina-yarberry
Niraparib. and . Temozolomide. in Patients with...
The Use of PARP Inhibitors in Breast Cancer: Challenges
by calandra-battersby
and Opportunities. This program will include a di...
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Updates in Ovarian Cancer Care
by ellena-manuel
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
Updates in Ovarian Cancer Care
by tatiana-dople
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
8II251M8269GQ526E59I95Z95I58651I295I
by faith
:-;.*89! ! ! !"##$% & '&()%*#$+%#, & '&(-*."%/.#, ...
Triple Conjunction of Jupiter and Saturn
by marina-yarberry
(1352.3) 122:8.7 These wise men saw no star to gu...
Triple Conjunction of Jupiter and Saturn
by jane-oiler
(1352.3) 122:8.7 These wise men saw no star to gu...
What Clinicians Want to Know:
by violet
Understanding the Factors Affecting the Optimal Di...
Year in Review Prostate Cancer
by faith
Emmanuel . S . Antonarakis. , MD. Professor of Onc...
Genomic Prostate Cancer Testing for Olaparib
by abigail
Laura Yarram-Smith . Solid Tumour Lead SWGLH. J...
NEw developments IN gynecological Oncology
by cheryl-pisano
highlights from the. EUROPEAN . society . of med...
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
by karlyn-bohler
Phase I Study of Olaparib and Temozolomide, in pa...
Ovarian cancer update Kentucky cancer Registry
by danika-pritchard
9/8/2016 . Erica . Takimoto. , D.O., F.A.C.O.O.G....
1 Svetlana Jeremić 1 , Ana Kesić
by esther
2. , Jelena Đorović Jovanović. 2. , Biljana Pet...
Arsenic-Induces Dysfunction in Poly(ADP-Ribose) Polymerase-1:
by holly
Arsenic Contamination in Potable Water and an Asse...
Last edited 06112018
by linda
DwACT ...
Policies Procedures and Documents
by naomi
Course Loads Full-Time and Half-Time DesignationPa...
PackageFOCIMarch192021TypePackageTitleFeatureOrderingbyConditionalI
by elysha
2codec codecEstimatetheconditionaldependencecoef&#...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
ASCO 2019 NSCLC - PARP & Chemotherapy
by mitsue-stanley
ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...
Cancer Chemotherapy Part I: General Cancer Chemotherapy
by ellena-manuel
Chapter 16; Pages 797 to 815A. also Section 16.11...
Precision Medicine in the management of gynecologic cancers
by stefany-barnette
Randal West, MD. Ovarian cancer standard of care....
State of the Art in BRCA
by ellena-manuel
-Mutated Ovarian Cancer. This program will includ...
Growth Patterns and Pathobiology of Experimental and
by pamella-moone
Clinical Malignancies. In Vivo. Updated: March . ...
Service Provider Application
by sherrill-nordquist
NYC Recovers Fiscal Year 201 6 I. OVERVIEW ParP of...
A Cancer
by stefany-barnette
Knowledge Network. Accelerate . cancer R&D. B...
PCR Application:
by alexa-scheidler
Can Breast Cancer be Cured?. Normal, Healthy Cell...
Load More...
